Is Sanjivani Paranteral Ltd (531569) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Sanjivani Paranteral Ltd is a average quality company .

Is Sanjivani Paranteral Ltd (531569) undervalued or overvalued?

The key valuation ratios of Sanjivani Paranteral Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone .

What is Sanjivani Paranteral Ltd (531569) share price return in the past 10 years?

Sanjivani Paranteral Ltd share price has appreciated 17.1% annually (CAGR) over the past ten years.

Is Sanjivani Paranteral Ltd (531569) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sanjivani Paranteral Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Sanjivani Paranteral Ltd (531569)?

Company share prices are keep on changing according to the market conditions. The current trading price of Sanjivani Paranteral Ltd (531569) on 07-May-2026 15:07:00 at 15:07 is 167.00.

What is the P/E ratio of Sanjivani Paranteral?

The latest standalone P/E ratio of Sanjivani Paranteral as of 07-May-2026 is 24.96.

What is the P/B ratio of Sanjivani Paranteral Ltd (531569)?

The latest standalone P/B ratio of Sanjivani Paranteral Ltd (531569) as of 07-May-2026 is 4.30.

What is the 52-week high and low of Sanjivani Paranteral Ltd (531569)?

The 52-week high of Sanjivani Paranteral Ltd (531569) is Rs. 268.80 and the 52-week low is Rs. 132.50.

Sanjivani Paranteral Ltd (531569) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Sanjivani Paranteral Ltd (531569)
Brand: Sanjivani Paranteral

Sanjivani Paranteral Ltd (531569) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Sanjivani Paranteral Ltd (531569)

BSE: 531569 NSE:

Key Metrics

Market Cap

₹204 Cr.

P/E Ratio

24.96

Price to Book (P/B)

4.30

Price to Sales (P/S)

2.82

EV/EBITDA

17.47

Return on Capital Employed (ROCE)

30.22%

Current Price

₹167

Return on Equity (ROE)

25.92%

Return on Assets (ROA)

14.95%

Operating Profit Margin

14.7%

Net Profit Margin

11.56%

Gross Profit Margin

15.4%

Book Value per Share

₹38.6

Sales Growth (YoY)

28.84%

Sales Growth (3 Years)

31.81%

Operating Profit Growth (1 Year)

28.3%

Operating Profit Growth (3 Years)

34.28%

Net Profit Growth (1 Year)

31.28%

52-Week Low / High

₹133 / 269

Net Profit Growth (3 Years)

18.68%

Dividend Yield

0.21%

Promoter Holding

31.26%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Stock return of Sanjivani Paranteral Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 16.7% based on the current price.

Q.1 Revenue growth of Sanjivani Paranteral Ltd?

Sanjivani Paranteral Ltd revenue growth is 28.8% for FY-2025, which is below its 5-year CAGR of 33.78%, indicating slower growth.

Q.1 Which industry/sub-sector does Sanjivani Paranteral Ltd belong to?

Sanjivani Paranteral Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.1 Promoter shareholding and pledge status of Sanjivani Paranteral Ltd?

Promoters hold 31.26% of the Sanjivani Paranteral Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of Sanjivani Paranteral Ltd vs industry peers?

Sanjivani Paranteral Ltd revenue CAGR is 33.78%, compared to the industry median CAGR of 8.30%, indicating faster growth and gaining its market share.

DeciZen - make an informed investing decision on Sanjivani Paranteral

Based on:

Data

Overall Rating ⓘ
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation ⓘ

3. Price Trend

Sanjivani Paranteral stock performance

Key Ratios

Is Sanjivani Paranteral Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	-7.3%	-33%	-227.3%	0%	-266%	266.4%	0%	0%	55.3%	30.2%	-
Value Creation Index ⓘ	-1.5	NA	NA	NA	NA	18.0	NA	NA	3.0	1.2	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	115	32.7	18	25.1	16.4	25.1	30.6	35.5	54.4	70.1	72
Sales YoY Gr.	-	-71.7%	-45%	39.7%	-34.8%	53.4%	22%	15.9%	53.3%	28.8%	-
Adj EPS ⓘ	-25.2	-46	-90	-3.7	-3.2	1.5	4.7	4.2	5	6.4	6.7
YoY Gr.	-	NA	NA	NA	NA	NA	214.8%	-10.9%	20.3%	26.4%	-
BVPS (₹) ⓘ	29.7	-14.8	-89.6	-80	-82.9	-52.8	-7.6	-3.1	22.1	30.8	38.6
Adj Net Profit ⓘ	-14.9	-27.2	-53.1	-2.2	-1.9	1.3	4.7	4.2	5.9	7.6	8
Cash Flow from Ops. ⓘ	0.5	9.6	3.1	2.5	-0.2	0.6	8.5	4.7	-10.7	-0.2	-
Debt/CF from Ops. ⓘ	139.7	6.3	15.8	19.4	-280.1	79	0.7	0.5	-0.1	-23.6	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-5.4%	33.8%	31.8%	28.8%
Adj EPS ⓘ	NA	NA	10.7%	26.4%
BVPSⓘ	0.4%	NA	NA	39.3%
Share Price	17.1%	71.7%	44.8%	-28.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-60	-618.2	172.5	4.4	3.9	-2.7	-17.9	-78.4	47.3	23	19.1
Op. Profit Mgn % ⓘ	-4.8	-70.4	-289.8	-7	-3.4	8.5	13.9	14.8	14.7	14.7	15.3
Net Profit Mgn % ⓘ	-12.9	-83.1	-295.5	-8.7	-11.3	5.1	15.3	11.8	10.8	10.8	11.3
Debt to Equity ⓘ	3.6	-6.9	-0.9	-1	-1	-1	-0.8	-0.8	0	0.2	-
Working Cap Days ⓘ	284	722	649	171	179	133	128	121	124	163	94
Cash Conv. Cycle ⓘ	221	567	420	-105	-169	-112	-90	-82	0	31	58

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	6.7	6.7
TTM Sales (₹ Cr.)	72.4	73.6
BVPS (₹) ⓘ	38.6	38.8
Reserves (₹ Cr.) ⓘ	35	35
P/BV ⓘ	4.30	4.29
PE ⓘ	24.96	24.68

From the Market
52 Week Low / High (₹)	132.50 / 268.80
All Time Low / High (₹)	1.76 / 396.95
Market Cap (₹ Cr.)	204
Equity (₹ Cr.)	12.3
Face Value (₹)	10
Industry PE ⓘ	44.8

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Sanjivani Paranteral - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	115	33	18	25	16	25	31	35	54	70
Operating Expenses ⓘ +	121	56	70	27	17	23	26	30	46	60
Manufacturing Costs	2	2	2	1	1	2	3	3	4	5
Material Costs	113	28	25	15	9	15	12	19	28	40
Employee Cost	3	3	3	2	2	2	3	3	4	5
Other Costs ⓘ	4	23	40	8	4	4	8	5	10	10
Operating Profit ⓘ	-6	-23	-52	-2	-1	2	4	5	8	10
Operating Profit Margin (%)	-4.8%	-71.2%	-290.0%	-7.0%	-3.4%	8.5%	13.9%	14.8%	14.7%	14.7%
Other Income ⓘ +	1	3	0	1	0	0	2	1	1	1
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	9	5	0	0	1	0	0	0	0	1
Depreciation ⓘ	1	1	1	1	1	1	1	1	1	1
Profit Before Tax ⓘ	-15	-26	-53	-2	-2	1	5	5	8	10
Tax ⓘ	-0	-0	-0	-0	-0	-0	0	0	1	2
Profit After Tax	-15	-26	-53	-2	-2	1	5	5	6	8
PAT Margin (%)	-12.7%	-80.3%	-295.0%	-8.2%	-10.4%	5.7%	15.8%	12.7%	11.3%	11.6%
Adjusted EPS (₹)	-24.8	-44.5	-90.0	-3.5	-2.9	1.7	4.9	4.5	5.3	6.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	7.30%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	18	-9	-53	-47	-49	-45	-8	-3	26	37
Share Capital ⓘ	6	6	6	6	6	8	10	10	12	12
Reserves ⓘ	12	-15	-59	-53	-55	-53	-18	-13	14	25
Debt +	61	57	45	45	45	42	3	1	1	5
Long Term Debt	12	7	4	8	8	5	3	1	1	5
Short Term Debt	49	50	41	37	37	37	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	6	3	12	12	11	11	11	14	6	15
Others Liabilities ⓘ	9	8	21	8	9	12	12	10	11	8
Total Liabilities ⓘ	93	60	25	18	16	19	18	21	43	65
Fixed Assets
Net Fixed Assets ⓘ +	13	11	10	9	8	8	7	8	10	21
Gross Block	22	22	22	22	22	22	23	24	27	38
Accumulated Depreciation	9	11	12	13	14	14	15	16	17	18
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	3
Inventories	20	10	2	1	2	1	2	5	10	10
Trade Receivables	48	32	5	5	1	7	5	2	5	17
Cash Equivalents	0	0	0	0	0	0	0	0	10	2
Others Assets ⓘ	12	7	7	3	5	4	4	6	9	13
Total Assets ⓘ	93	60	25	18	16	19	18	21	43	65

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0	10	3	2	-0	1	9	5	-11	-0
PBT ⓘ	-15	-17	-53	-2	-2	1	5	5	8	10
Adjustment ⓘ	9	6	2	1	2	1	-1	1	1	1
Changes in Working Capital ⓘ	6	21	55	3	0	-2	4	-1	-18	-10
Tax Paid ⓘ	-0	0	0	-0	-0	-0	-0	-0	-1	-1
Cash Flow From Investing Activity ⓘ +	-1	0	-0	0	-0	-0	-1	-1	-12	-6
Capex	-1	0	-0	0	-0	-0	-1	-1	-3	-11
Net Investments	0	0	0	0	0	0	0	0	-9	8
Others ⓘ	0	0	0	0	0	0	0	0	0	-3
Cash Flow From Financing Activity ⓘ +	-1	-10	-3	-2	0	-0	-8	-4	23	6
Net Proceeds from Shares ⓘ	0	0	0	0	0	3	2	0	25	2
Net Proceeds from Borrowing ⓘ	8	-5	-3	4	1	0	0	0	0	0
Interest Paid ⓘ	-8	-5	-0	-0	-1	-0	-0	-0	-0	-1
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	-6	0	-3	-9	-3	-2	5
Net Cash Flow ⓘ	-1	-0	0	0	0	-0	0	-0	0	0

Finance Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-58.98	N/A	N/A	N/A	N/A	N/A	N/A	N/A	54.08	25.92
ROCE (%)	-7.28	N/A	N/A	N/A	N/A	N/A	N/A	N/A	55.32	30.22
Asset Turnover Ratio	1.12	0.43	0.42	1.17	0.97	1.47	1.66	1.81	1.69	1.31
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	1	1.8	1	-1.83	-0
Working Capital Days
Receivable Days	181.80	445.90	378.40	76.50	70	54.80	67.70	35.40	22.40	54.80
Inventory Days	67.60	167.60	124.10	21.40	24.80	18.30	15.60	36.40	50.50	51.70
Payable Days	29.80	60.30	108.10	288.80	460.60	263.60	326.70	247.40	124.70	94.70

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Sanjivani Paranteral Ltd FAQs

The current trading price of Sanjivani Paranteral on 07-May-2026 15:07 is ₹167.0.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 06-May-2026 the market cap of Sanjivani Paranteral stood at ₹204.0 Cr

The latest P/E ratio of Sanjivani Paranteral as of 06-May-2026 is 24.96.

The latest P/B ratio of Sanjivani Paranteral as of 06-May-2026 is 4.30.

The 52-week high of Sanjivani Paranteral is ₹268.8 and the 52-week low is ₹132.5.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sanjivani Paranteral is ₹72.43 ( Cr.) .

About Sanjivani Paranteral Ltd

Sanjivani Parenteral was established in 1997 by A H Khemka, Ashwin Khemka and Somesh Khemka, under the technical direction of Mahendra Kalwankar. It is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices. The core product range of the companyâ€™s products includes oral solids, small volume parenterals and sterile powder formulations.

The company has grown many folds and aspires to be a respected research-based company. With its diverse product portfolio, it is rapidly expanding its reach to the global marketplace, riding on its success in India and in the worldâ€™s emerging and developed markets.

After establishing itself in India, Sanjivani has extended its reach globally by entering the markets of Asia, Europe, Africa and Latin America. The company has active presence in countries like Russia, Ukraine, Uzbekistan, Turkmenistan, Fiji, Vietnam, Sri Lanka, Nepal, Malaysia, Thailand, Nigeria and Peru, to name a few. Sanjivani Parenteral has also got its plant approved by the registration authorities of Congo, Sudan and Sri Lanka. It is making its presence felt in the world market now, through leveraging its manufacturing capacity, quality of products and international alliances.

International business contributes about 30% of the companyâ€™s revenue and is set to grow to more than 50% in the coming two years. This includes the sales of Sanjivaniâ€™s own brands and the revenue from the contract manufacturing services that the company provides to its overseas clients. The company is in the making of a strong base to broaden its horizons.

Sanjivani has been a regular supplier to the armed forcesâ€™ hospitals in India. Furthermore, many government and private hospitals have availed of the products and services offered by Sanjivani across the country. The company also has its own marketing operations in India and boasts of over 1000 distributors all over India.

Products

Therapeutic Products
Animal Products
Key Products
Oral Solids

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Sanjivani Paranteral Ltd (531569) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Sanjivani Paranteral Share Price